Philips CX50 xMATRIX Offers World-Class Interventional and Diagnostic Features on Single Portable System

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG, AEX: PHIA) announced that CX50 xMATRIX, the world's first portable ultrasound with Philips' industry leading Live 3D TEE, now offers 2-D Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available Live 3D TEE and ICE is shown in Paris at the EuroPCR, official meeting for the European Association of Percutaneous Cardiovascular Inventions (EAPCI), May 21-24.

Since its launch in 2012, Philips CX50 xMATRIX has been the only ultrasound system with the flexibility of a portable system together with Live 3D TEE capability. Now, Philips has partnered with St. Jude Medical (NYSE:STJ), a global medical device company based in St. Paul, Minn., to integrate the CX50 xMATRIX with the St. Jude Medical ViewFlex™ Xtra Intracardiac Echocardiography (ICE) Catheter. The ViewFlex Xtra ICE catheter is a new, 2-D catheter featuring four-way steering and the unique benefit of single-handed control.

With the increase in minimally invasive structural heart disease (SHD) repairs and electrophyiosology (EP) procedures comes an increase in the need for ICE for visualization of intracardiac anatomy from the right atrium. ICE is commonly used in procedures such as left atrial ablation and closure of Patent Foramen Ovale (PFO) and Atrial Septal Defects (ASD). With Live 3D TEE and ICE both available on the CX50 xMATRIX, interventional teams can visualize these and other repairs that may benefit from Live 3D TEE such as Transcatheter Aortic Valve Implantation (TAVI), multi-fenestrated and irregular ASD closures, and other complex SHD repairs.

The CX50 xMATRIX is an all-in-one imaging solution for cardiac catheterization labs, EP labs and hybrid operating rooms. With both ICE and Live 3D TEE available on a single system, hospitals will not need to rely on scheduling two separate ultrasound systems for various procedures. The CX50 xMATRIX also offers interventional workflow features such as Philips Allura tableside control, automatic patient data exchange, and support for Philips' EchoNavigator - which intelligently combines fluoroscopy and echocardiography.

"Our cardiology customers have clearly told us that one of the most exciting opportunities for patient care involves minimally invasive repairs, and that performing a wide range of procedures requires exceptional ultrasound imaging - not only Philips Live 3D TEE but also world-class ICE," said Conrad Smits, CEO Ultrasound, for Philips Healthcare. "Working with another industry leader, St. Jude Medical, we have created a partnership that delivers a premium compact integrated solution to exceed the clinical and business needs of our cardiology customers."

About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...